Hydrocision said today that it inked an exclusive worldwide licensing deal to allow Procept BioRobotics to use its pump cartridge technology for urological applications. Through the agreement, Redwood Shores, Calif.-based Procept BioRobotics will gain the rights to use Boston-based Hydrocision’s pump cartridge technology in its AquaBeam robotic system designed to performed autonomous tissue removal for […]
HydroCision names Tranchemontagne as CEO | Personnel Moves – March 12, 2019
HydroCision said early this month that it tapped former Smith & Nephew (NYSE:SNN) exec Alain Tranchemontagne as its new chief executive officer. Prior to joining Boston-based HydroCision, Tranchemontagne held a position as U.S. business commercial development senior VP at Smith & Nephew. Before joining Smith & Nephew, Tranchemontagne also held positions at Covidien in senior marketing roles […]
AngioDynamics taps Concert Medical president Donnelly as chairman
AngioDynamics (NSDQ:ANGO) said today that it tapped Concert Medical president Howard Donnelly to replace outgoing chairman Vincent Bucci.
Bucci, 1st named to the AngioDynamics board in 2007, was named chairman later that year. He stepped down in March.
HydroCision touts positive results for water-jet discectomy device
Surgical waterjet maker HydroCision touted positive results for its Hydrodiscectomy procedure published in the Internet Spine Journal, showing a 94% improvement in back and leg pain.
The HydroCision device uses a high-pressure water jet to cut and compress herniated discs during discectomy, according to a press release.
Sign up to get our free newsletters delivered right to your inbox.
[sead]
VC firms buy majority stake in HydroCision, announce new CEO
Volcano Capital, Bioventures and Omega Funds bought a majority stake in HydroCision Inc. for an unspecified amount, tapping Howard Donnelly to be the company’s new president and CEO.
Donnelly assumed the top spot at the Billerica, Mass.-based company in July, according to Forbes, after also becoming a principal in the firm. His resumé includes stints as president of Smiths Group subsidiary Level 1 Inc. and executive positions at Pfizer Inc.
